« back

Movember: Global Collaborative Program to Reduce Disease Progression in Prostate Cancer

  Wednesday, 05 Jan 2022 | Funding Deadline

Movember, in collaboration with Prostate Cancer UK, is pleased to invite expressions of interest (EOI) from suitably qualified and experienced research teams to participate in a new, global, collaboratively designed program. The goal of this Program is to accelerate efforts aimed at reducing the number of men who progress to advanced prostate cancer, by bringing together a network of disciplines within the prostate cancer research community.

The Network, in its final form, will comprise over 600 participating hospitals and research institutions across 19 countries, with the aims to accelerate improvements in the survival and quality of life of men living with prostate and testicular cancer. The Network will provide an opportunity for this global collaborative program to fast-track the delivery of lifesaving tests and treatments to improve the physical and mental health of men living with the disease.

 

Deadline for expression of interest: 05 January 2022

Find out more here